Thomas Barton May

Title: Innovations of Thomas Barton May

Introduction

Thomas Barton May is an accomplished inventor based in Grayslake, Illinois. He has made significant contributions to the field of pharmaceuticals, holding a total of four patents. His work focuses on developing stable formulations that enhance the efficacy of therapeutic agents.

Latest Patents

Among his latest patents, one notable invention is related to cosolvent formulations. This patent discloses stable pharmaceutical formulations that include a therapeutic agent, a low molecular weight alcohol, and a glycol derivative. Preferred formulations in this patent include 19-nor-1α,3β,25-trihydroxy-9,10-secoergosta-5,7(E),22(E)-triene. Another significant patent is for a propofol composition. This invention pertains to a sterile pharmaceutical composition comprising a propofol-containing oil-in-water emulsion formulation. It includes antimicrobial agents such as benzyl alcohol and ethylene diamine tetra acetic acid, benzethonium chloride, and sodium benzoate.

Career Highlights

Thomas Barton May is currently associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. His work at Abbott has allowed him to focus on innovative pharmaceutical solutions that address critical health needs.

Collaborations

Throughout his career, Thomas has collaborated with notable colleagues, including John M Hofstetter and Kathleen L Olson. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Thomas Barton May's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare through effective formulations. His patents reflect a deep understanding of the complexities involved in drug development.